Sertraline Hydrochloride Tablet
Product Images NDC 72865-207

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 72865-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg (100mg 180s)

Each film-coated tablet of sertraline hydrochloride, manufactured by Ascent Pharmaceuticals, Inc., contains 111.9mg of the active ingredient equivalent to 100mg of sertraline. The dosage and usage of sertraline products can be found in the prescribing information which is provided with the medication. Store the medication at 20-25°C (68-77°F), which is classified as USP controlled room temperature. This medication is supplied in a bottle that contains 180 tablets and is recommended for dispensing by pharmacists only. The manufacturer is XL Care Pharmaceuticals, Inc. located in Lawrenceville, GA.*

FDA Label Image

100 mg (100mg 30s)

This is a medication label for sertraline hydrochloride tablets, USP. Each film-coated tablet contains 111.9mg of sertraline hydrochloride equivalent to 100mg of sertraline. The dosage and use details are available in the accompanying prescription information. The tablets should be stored at 20°C to 25°C (68°F to 77°F) in a controlled environment. These tablets are manufactured by Ascent Pharmaceuticals, Inc. and are available in a pack of 30 tablets. The label also has information for pharmacists to dispense the medication along with a medication guide that should be provided to each patient separately.*

FDA Label Image

100 mg (100mg 500s)

This is a description of a medication called Sertraline Hydrochloride Tablets, USP made by XLcare Pharmaceuticals Inc. The prescription is for 100mg tablets, with 500 tablets supplied. Each tablet contains 111.9mg of Sertraline Hydrochloride, equivalent to 100mg of Sertraline. There are specific dosage and usage instructions, which can be found in the prescribing information provided. The medication should be stored at a temperature of 20 to 25°C.*

FDA Label Image

100 mg (100mg 90s)

Each film-coated tablet contains 111.9 mg sertraline hydrochloride equivalent to 100 mg sertraline. Dosage instructions can be found in the accompanying prescribing information. The tablets should be stored at a controlled room temperature. Manufactured by Ascent Pharmaceuticals and distributed by XLCare Pharmaceuticals. A medication guide is provided to each patient. 90 tablets are included in a pack. This medication requires a prescription.*

FDA Label Image

25 mg (25 mg 500s)

This is a description of Sertraline Hydrochloride Tablets, USP manufactured by XLcare Pharmaceuticals Inc. The tablets contain 28 mg of sertraline hydrochloride equivalent to 25 mg of sertraline. The tablets are film-coated and come in a package of 500. A medication guide is provided to each patient. The prescribing information should be consulted for dosage and use. The tablets should be stored at controlled room temperature. They are manufactured by Ascent Pharmaceuticals, Inc. and distributed by XLCare Pharmaceuticals, Inc. Rx only.*

FDA Label Image

25 mg (25mg 180s)

XLcare Pharmaceuticals Inc. provides Sertraline Hydrochloride Tablets, USP at a strength of 25 mg. Each film-coated tablet contains 28 mg of sertraline hydrochloride, equivalent to 25 mg of sertraline. The medication guide should be provided to each patient by the pharmacist. Dosage and usage information can be found in the accompanying prescribing information. The tablets should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F). Ascent Pharmaceuticals, Inc. manufactures the tablets for XLcare Pharmaceuticals, Inc. at their locations in Central Islip, NY, and Lawrenceville, GA.*

FDA Label Image

25 mg (25mg 30s)

This is the description: Sertraline Hydrochloride Tablets, USP is an antidepressant medication. The tablets are film-coated and contain 28 mg of sertraline hydrochloride, which is equivalent to 25 mg of sertraline. It is important for pharmacists to dispense the Medioation Guide provided separately to each patient. Dosage and use instructions are included in the prescribing information. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The tablets were manufactured by Ascent Pharmaceuticals, Inc. in Central Islip, NY and distributed by XLCare Pharmaceuticals, Inc. in Lawrenceville, GA.*

FDA Label Image

25 mg (25mg 90s)

This is a description of Sertraline Hydrochloride Tablets, USP produced by XLCare Pharmaceuticals. It includes important information about dosage, usage, and storage of the medication. The tablets contain 28 mg of sertraline hydrochloride equivalent to 25 mg of sertraline. The medication guide is provided separately to each patient by the pharmacist. The drug is prescription only and comes in a package of 90 tablets. It is manufactured by Ascent Pharmaceuticals and is to be stored at controlled room temperature.*

FDA Label Image

50 mg (50mg 180s)

XLcare Pharmaceuticals Inc. manufactures Sertraline Hydrochloride Tablets, USP with NDC 72865-206-18. Each tablet contains 56 mg sertraline hydrochloride equivalent to 50 mg sertraline. The medication is Rx only and comes with a Medioation Guide provided separately to each patient. Dosage and Use information can be found in the accompanying prescribing information. It is recommended to store the tablets at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. They are manufactured by Ascent Pharmaceuticals, Inc. and manufactured for XLCare Pharmaceuticals, Inc., located at 242 South Culver Street, Suite 202, Lawrenceville, GA 30046. The revision date is 08/21.*

FDA Label Image

50 mg (50mg 30s)

Each film-coated tablet contains 56 mg sertraline hydrochloride equivalent to 50 mg sertraline. Dosage and use information can be found in the accompanying prescribing information. Store at 20°C to 25°C (68°F to 77°F). These tablets are manufactured by Ascent Pharmaceuticals, Inc. for XLCare Pharmaceuticals, Inc. and must be dispensed by a pharmacist with a provided guide for each patient. This description is for sertraline hydrochloride tablets, USP.*

FDA Label Image

50 mg (50mg 500s)

XLcare is a medication consisting of film-coated tablets containing 56mg AL sertraline hydrochloride which is equivalent to 50mg of sertraline. The dosages, usage instructions, and other relevant information can be found in the accompanying prescription guide. The medication should be stored between 20°C to 25°C. The tablets are manufactured by Ascent Pharmaceuticals, Inc. for XLCare Pharmaceuticals, Inc. A pharmacist dispenses the medication, and each patient receives a separate guide. The manufacturer is located in Central Ilip, NY, and XLCare's location is Lawrenceville, GA.*

FDA Label Image

50 mg (50mg 90s)

Each film-coated tablet contains 56 mg sertraline hydrochloride equivalent to 50 mg sertraline. Dosage and use information should be obtained from accompanying prescribing information. Store at 20°C to 25°C. Manufactured by Ascent Pharmaceuticals, Inc. for XL Care Pharmaceuticals, Inc. Pharmacist should dispense medication guide separately to each patient. This product contains 90 tablets and is available only by prescription.*

FDA Label Image

Serious Symptoms (Serioussymptoms)

This text describes some symptoms that a person may experience during a medical emergency. These symptoms include high fever, uncontrolled muscle spasms, stiff muscles, rapid changes in heart rate or blood pressure, confusion, and loss of consciousness. It is important to seek medical attention immediately if these symptoms occur.*

FDA Label Image

Common Side Effects (Commonsideeffect)

This text appears to be describing some of the possible side effects of a medication or medical condition. Symptoms mentioned include nausea, loss of appetite, diarrhea, indigestion, changes in sleep habits, increased sweating, sexual problems, tremors, fatigue, agitation, and anxiety. It is not clear what medication or condition is being referred to.*

FDA Label Image

Health Problems (Healthproblem)

This text appears to be a list of possible medical conditions or histories that could affect a person's health or medical treatment. It mentions liver problems, kidney problems, a history of stroke, heart problems, seizures, convulsions, high blood pressure, bipolar disorder or mania, low sodium levels in the blood, and bleeding problems. These conditions may need to be taken into consideration when diagnosing or treating a patient.*

FDA Label Image

Structure (Struct)

This appears to be a chemical formula notation for two elements: Chlorine (Cl) and Hydrogen Chloride (HCI). However, without additional context, it is not possible to provide a specific description or application.*

FDA Label Image

Symptoms 1 (Symptoms 1)

This text describes warning signs of a possible mental health crisis, including suicidal ideation or attempts, aggression, depression, restlessness or agitation, dangerous impulses, anxiety, panic attacks, sleep disturbances, and other changes in behavior or mood. These symptoms may indicate a need for immediate professional help and support.*

FDA Label Image

Symptoms 2 (Symptoms 2)

These are some of the symptoms of a medical condition that can result in changes in mental status, including agitation, hallucinations, coma or other changes. Some other symptoms can include nausea, vomiting, or diarrhea, a racing heartbeat, high or low blood pressure, sweating or fever. Additionally, there may be coordination problems or muscle twitching, overactive reflexes and muscle rigidity. The exact condition that may be associated with these symptoms is not available.*

FDA Label Image

Symptoms 4 (Symptoms 4)

This is a description of symptoms commonly associated with bipolar disorder, specifically the manic or hypomanic states. These symptoms include increased energy, trouble sleeping, excessive happiness or irritability, racing thoughts, reckless behavior, talking more or faster than usual, and unusually grand ideas. If someone is experiencing these symptoms, it is important to seek the help of a mental health professional.*

FDA Label Image

Symptoms 8

This text seems to describe common symptoms of a medical condition that may include headaches, weakness or a feeling of weakness, confusion, problems concentrating, unsteadiness or thinking difficulties, and memory problems. It is difficult to determine the specific medical condition without additional context.*

FDA Label Image

Table1

The text describes a table providing recommended daily dosages for sertraline hydrochloride in patients with certain mental health conditions such as MDD, OCD, PD, PTSD, and SAD. The table provides starting doses and therapeutic ranges for adults and pediatric patients with different age groups for OCD.*

FDA Label Image

Table 2 (Table2)

This is a table presenting the risk differences of the number of cases of suicidal thoughts or behaviors in the pooled placebo-controlled trials of antidepressants in pediatric and adult patients. The table shows the age range and the drug-placebo difference in the number of patients with suicidal thoughts or behaviors per 1000 patients treated. The differences are presented in both increases and decreases compared to placebo.*

FDA Label Image

Table 3 (Table3)

This text provides a table showing common adverse reactions in adults with several mental health conditions who were involved in pooled placebo-controlled trials for a drug called Sertraline Hydrochloride. The table lists various side effects such as decreased appetite, dizziness, and visual impairment, among others. The table also indicates the percentage of patients who experienced each side effect and how it compared to the percentage of patients in the placebo group who experienced them.*

FDA Label Image

Table 4 (Table4)

This is a table presenting the most common sexual adverse reactions in adult men and women with various conditions, such as MDD and PTSD, who took sertraline hydrochloride. The table presents the percentage of individuals who experienced specific reactions such as ejaculation failure, libido decreased, erectile dysfunction, and ejaculation disorder. These reactions were compared to a placebo group.*

FDA Label Image

Table 5 (Table5)

Table 5 provides a list of clinically significant drug interactions with Sertraline Hydrochloride. The concomitant use of MAOIs including Sertraline Hydrochloride and MAOIs increases the risk of serotonin syndrome. The use of serotonergic drugs with Sertraline Hydrochloride also increases the risk of serotonin syndrome. Concurrent use of an antiplatelet agent or anticoagulant with Sertraline Hydrochloride may potentiate the risk of bleeding associated with the concomitant use of Sertraline Hydrochloride and anticoagulants. Use of Sertraline Hydrochloride with a drug that is highly bound to plasma protein may increase the concentration of Sertraline Hydrochloride. Concurrent use of Sertraline Hydrochloride with a CYP2D6 substrate may increase the exposure of the CYP2D6 substrate. The use of Phenitoins and drugs that prolong the QT interval with Sertraline Hydrochloride must be monitored.*

FDA Label Image

Treatment (Treatment)

This is a list of common mental health disorders, including Major Depressive Disorder, Obsessive Compulsive Disorder, Panic Disorder, Posttraumatic Stress Disorder, Social Anxiety Disorder, and Premenstrual Dysphoric Disorder.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.